Cargando…
PD-1 Inhibitors Plus Capecitabine as Maintenance Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Case Report and Review of Literature
Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary liver cancer with a poor prognosis. Recently, an immunotherapy strategy represented by programmed cell death 1 (PD-1) inhibitors has been applied to the systemic treatment of advanced iCCA. However, immunotherapy combined with...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739978/ https://www.ncbi.nlm.nih.gov/pubmed/35003124 http://dx.doi.org/10.3389/fimmu.2021.799822 |
_version_ | 1784629216978927616 |
---|---|
author | Wang, Zhihong Zeng, Tianmei Li, Yong Zhang, Ding Yuan, Zhengang Huang, Mengli Yang, Yuan Zhou, Weiping |
author_facet | Wang, Zhihong Zeng, Tianmei Li, Yong Zhang, Ding Yuan, Zhengang Huang, Mengli Yang, Yuan Zhou, Weiping |
author_sort | Wang, Zhihong |
collection | PubMed |
description | Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary liver cancer with a poor prognosis. Recently, an immunotherapy strategy represented by programmed cell death 1 (PD-1) inhibitors has been applied to the systemic treatment of advanced iCCA. However, immunotherapy combined with chemotherapy as first-line maintenance therapy was rarely reported. Our report presented an advanced iCCA patient who had a dramatic response to the PD-1 inhibitor sintilimab combined with gemcitabine plus cisplatin as the first-line therapy and sintilimab combined with capecitabine as maintenance therapy, yielding an ongoing progression-free survival of 16 months. |
format | Online Article Text |
id | pubmed-8739978 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87399782022-01-08 PD-1 Inhibitors Plus Capecitabine as Maintenance Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Case Report and Review of Literature Wang, Zhihong Zeng, Tianmei Li, Yong Zhang, Ding Yuan, Zhengang Huang, Mengli Yang, Yuan Zhou, Weiping Front Immunol Immunology Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary liver cancer with a poor prognosis. Recently, an immunotherapy strategy represented by programmed cell death 1 (PD-1) inhibitors has been applied to the systemic treatment of advanced iCCA. However, immunotherapy combined with chemotherapy as first-line maintenance therapy was rarely reported. Our report presented an advanced iCCA patient who had a dramatic response to the PD-1 inhibitor sintilimab combined with gemcitabine plus cisplatin as the first-line therapy and sintilimab combined with capecitabine as maintenance therapy, yielding an ongoing progression-free survival of 16 months. Frontiers Media S.A. 2021-12-24 /pmc/articles/PMC8739978/ /pubmed/35003124 http://dx.doi.org/10.3389/fimmu.2021.799822 Text en Copyright © 2021 Wang, Zeng, Li, Zhang, Yuan, Huang, Yang and Zhou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Wang, Zhihong Zeng, Tianmei Li, Yong Zhang, Ding Yuan, Zhengang Huang, Mengli Yang, Yuan Zhou, Weiping PD-1 Inhibitors Plus Capecitabine as Maintenance Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Case Report and Review of Literature |
title | PD-1 Inhibitors Plus Capecitabine as Maintenance Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Case Report and Review of Literature |
title_full | PD-1 Inhibitors Plus Capecitabine as Maintenance Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Case Report and Review of Literature |
title_fullStr | PD-1 Inhibitors Plus Capecitabine as Maintenance Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Case Report and Review of Literature |
title_full_unstemmed | PD-1 Inhibitors Plus Capecitabine as Maintenance Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Case Report and Review of Literature |
title_short | PD-1 Inhibitors Plus Capecitabine as Maintenance Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Case Report and Review of Literature |
title_sort | pd-1 inhibitors plus capecitabine as maintenance therapy for advanced intrahepatic cholangiocarcinoma: a case report and review of literature |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739978/ https://www.ncbi.nlm.nih.gov/pubmed/35003124 http://dx.doi.org/10.3389/fimmu.2021.799822 |
work_keys_str_mv | AT wangzhihong pd1inhibitorspluscapecitabineasmaintenancetherapyforadvancedintrahepaticcholangiocarcinomaacasereportandreviewofliterature AT zengtianmei pd1inhibitorspluscapecitabineasmaintenancetherapyforadvancedintrahepaticcholangiocarcinomaacasereportandreviewofliterature AT liyong pd1inhibitorspluscapecitabineasmaintenancetherapyforadvancedintrahepaticcholangiocarcinomaacasereportandreviewofliterature AT zhangding pd1inhibitorspluscapecitabineasmaintenancetherapyforadvancedintrahepaticcholangiocarcinomaacasereportandreviewofliterature AT yuanzhengang pd1inhibitorspluscapecitabineasmaintenancetherapyforadvancedintrahepaticcholangiocarcinomaacasereportandreviewofliterature AT huangmengli pd1inhibitorspluscapecitabineasmaintenancetherapyforadvancedintrahepaticcholangiocarcinomaacasereportandreviewofliterature AT yangyuan pd1inhibitorspluscapecitabineasmaintenancetherapyforadvancedintrahepaticcholangiocarcinomaacasereportandreviewofliterature AT zhouweiping pd1inhibitorspluscapecitabineasmaintenancetherapyforadvancedintrahepaticcholangiocarcinomaacasereportandreviewofliterature |